Successful, we will replay to you quickly.

OK

Please select the quantity.

OK

Your message is being sent, please wait.

Close

test

Close

Send mail failed, please send again!

Close

Products are for research use only. Not for human use. We do not sell to patients.

Signaling Pathway

Saracatinib

HY-10234

(AZD0530; AZD-0530; AZD 0530)

Saracatinib

Saracatinib Chemical Structure

Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck; less active for Abl and EGFR (L858R and L861Q).

Price and Availability of Saracatinib

  • Select country:
  • America
  • Europe
  • Others
Size Price Stock Quantity
10 mM * 1 mL $66 In-stock
10 mg $60 In-stock
50 mg $185 In-stock
100 mg $264 In-stock
200 mg Get quote
500 mg Get quote
Size Price Stock Quantity
10 mM * 1 mL €65 In-stock
10 mg €59 In-stock
50 mg €181 In-stock
100 mg €259 In-stock
200 mg Get quote
500 mg Get quote

Discount Prices Available for Larger Orders.

Inquiry Online

Hide
Salutation:
*Area: Country:
*Customer: *Company Name:
*Email: *Requested quantity:
Remarks:

Your information is safe with us

* Required Fields

Saracatinib Data Sheet

  • View current batch:

    Purity: 99.85%

  • Pdf Version Network Version

    DataSheet

    Pdf Version Network Version

    MSDS

    Pdf Version

    COA

Customer View

Related Compound Libraries

Inhibitor Kit

Biological Activity of Saracatinib

Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck; less active for Abl and EGFR (L858R and L861Q).
IC50 value: 2.7 nM(c-Src); 30 nM (v-Abl) [1]
Target: c-Src; v-Abl
in vitro: Saracatinib also potently inhibits other Src tyrosine kinase family members including c-Yes, Fyn, Lyn, Blk, Fgr, and Lck with IC50 from 4-10 nM. Saracatinib sensitively inhibits Src Y530F NIH 3T3 with IC50 of 80 nM. Saracatinib signi?cantly impairs the invasion of HT1080 cells through a 3-dimensional collagen matrix and completely inhibits EGF-induced cell scattering in NBT-II bladder cancer cells [1]. Saracatinib potent inhibits Src activation in DU145 and PC3 cells, which through inhibition of Y419 phosphorylation. Saracatinib inhibits the growth of prostate cancer including PC3, DU145, CWR22Rv1 and LNCaP, while Saracatinib shows low activity in LAPC-4, PZ-HPV7 and RWPE-1 cells. Saracatinib induces cell cycle arrest at G1/S but not caspase 3 cleavages. Saracatinib also significantly inhibits DU145 and PC3 migration in the Boyden chamber [2]. Saracatinib gives a potent and sustained blockage of AKT and enhances the sensitivity to irradiation in A549 and Calu-6 cells [3].
in vivo: Saracatinib shows great tumor growth inhibition in Src3T3 allografts and a moderate growth delay in Calu-6, MDA-MB-231, AsPc-1 and BT474C xenografts [1]. Saracatinib shows great antitumor activity in orthotopic DU145 xenograft mice at a dose of 25mg/kg (orally administered, daily) [2].

Chemical Information

M.Wt 542.03 Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Formula C27H32ClN5O5
CAS No 379231-04-6
Solvent & Solubility

DMSO 54 mg/ml

Preparing Stock Solutions

1 mg 5 mg 10 mg
1 mM 1.8449 mL 9.2246 mL 18.4492 mL
5 mM 0.3690 mL 1.8449 mL 3.6898 mL
10 mM 0.1845 mL 0.9225 mL 1.8449 mL

References on Saracatinib

  • Related Src Products

  • 1-Naphthyl PP1

    1-Naphthyl PP1(1-NA-PP 1) is a selective inhibitor of src family kinases v-Src and c-Fyn as well as the tyrosine kinase c-Abl (IC50 values are 1.0, 0.6, 0.6, 18 and 22 (mu)M for v-Src, c-Fyn, c-Abl, CDK2 and CAMK II respectively).

  • 1-NM-PP1

    1NM-PP1(PP1 Analog II) is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors(IC50=28 uM vSrc; 4.2 nM v-Src-as1 I338G).

  • A-770041

    A-770041 is selective and orally active Src-family Lck inhibitor; A-770041 is a 147 nM inhibitor of Lck (1 mM ATP) and is 300-fold selective against Fyn, the other Src family kinase involved in T-cell signaling.

  • AMG-47a

    AMG-47a is a potent inhibitor of Lck and T cell proliferation; exhibits anti-inflammatory activity (ED50 = 11 mg/kg) in the anti-CD3 induced production of IL-2 in mice.

  • AZM475271

    AZM475271 is a potent and selective Src kinase inhibitor with IC50 of 5 nM; no inhibitory activity on Flt3, KDR, Tie-2.

  • Bosutinib

  • KX1-004

    KX1-004 is a potent small molecule inhibitor of Src-PTK as a potential protective drug for NIHL.

  • Lck Inhibitor

    Lck Inhibitor is a new class of compounds that are potent inhibitors of Lck with an IC50 value of 7 nM.

  • PD173955

    PD173955 is src family-selective tyrosine kinase inhibitor with IC50 of ~22 nM for Src, Yes and Abl kinase; less potent for FGFR(alpha) and no activity on InsR and PKC.

  • PP1

    PP1(AGL 1872) is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.

MORE